Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP301447.RAPnDnoZe9hCvo3hXhfPZDui-raX7KdYNfErovareesfE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP301447.RAPnDnoZe9hCvo3hXhfPZDui-raX7KdYNfErovareesfE130_assertion type Assertion NP301447.RAPnDnoZe9hCvo3hXhfPZDui-raX7KdYNfErovareesfE130_head.
- NP301447.RAPnDnoZe9hCvo3hXhfPZDui-raX7KdYNfErovareesfE130_assertion description "[Frequent gains were detected in GLI1, GEFT, OS9, and CDK4 (12q13.3-q14.1), being 60% in embryonal rhabdomyosarcoma (ERMS) and 66.67% in alveolar rhabdomyosarcoma (ARMS), respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP301447.RAPnDnoZe9hCvo3hXhfPZDui-raX7KdYNfErovareesfE130_provenance.
- NP301447.RAPnDnoZe9hCvo3hXhfPZDui-raX7KdYNfErovareesfE130_assertion evidence source_evidence_literature NP301447.RAPnDnoZe9hCvo3hXhfPZDui-raX7KdYNfErovareesfE130_provenance.
- NP301447.RAPnDnoZe9hCvo3hXhfPZDui-raX7KdYNfErovareesfE130_assertion SIO_000772 24551291 NP301447.RAPnDnoZe9hCvo3hXhfPZDui-raX7KdYNfErovareesfE130_provenance.
- NP301447.RAPnDnoZe9hCvo3hXhfPZDui-raX7KdYNfErovareesfE130_assertion wasDerivedFrom befree-20150227 NP301447.RAPnDnoZe9hCvo3hXhfPZDui-raX7KdYNfErovareesfE130_provenance.
- NP301447.RAPnDnoZe9hCvo3hXhfPZDui-raX7KdYNfErovareesfE130_assertion wasGeneratedBy ECO_0000203 NP301447.RAPnDnoZe9hCvo3hXhfPZDui-raX7KdYNfErovareesfE130_provenance.